These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 12166599
1. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes? Frier BM. Int J Clin Pract Suppl; 2002 Jul; (129):12-9. PubMed ID: 12166599 [Abstract] [Full Text] [Related]
2. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes. Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR. Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114 [Abstract] [Full Text] [Related]
3. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670 [Abstract] [Full Text] [Related]
4. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, DARTS/MEMO Collaboration. Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627 [Abstract] [Full Text] [Related]
5. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge]. Ratzmann KP, Schimke E. Med Klin (Munich); 1995 Oct 15; 90(10):557-61. PubMed ID: 7500918 [Abstract] [Full Text] [Related]
6. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus. Holstein A, Hammer C, Plaschke A, Ptak M, Kuhn J, Diekmann J, Kleesiek K, Egberts EH. Exp Clin Endocrinol Diabetes; 2004 Sep 15; 112(8):429-34. PubMed ID: 15372362 [Abstract] [Full Text] [Related]
7. [Hypoglycemia--a dreaded complication of diabetes]. Bjørgaas M. Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2441-4. PubMed ID: 11475234 [Abstract] [Full Text] [Related]
8. How hypoglycaemia can affect the life of a person with diabetes. Frier BM. Diabetes Metab Res Rev; 2008 Feb 30; 24(2):87-92. PubMed ID: 18088077 [Abstract] [Full Text] [Related]
9. A comparative study of responses to acute hypoglycaemia induced by human and porcine insulins in patients with Type 1 diabetes. MacLeod KM, Gold AE, Frier BM. Diabet Med; 1996 Apr 30; 13(4):346-57. PubMed ID: 9162611 [Abstract] [Full Text] [Related]
10. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel. Curr Med Res Opin; 2009 Nov 30; 25(11):2643-54. PubMed ID: 19751116 [Abstract] [Full Text] [Related]
11. Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors. Pedersen-Bjergaard U. Dan Med Bull; 2009 Nov 30; 56(4):193-207. PubMed ID: 19939337 [Abstract] [Full Text] [Related]
12. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. de Galan BE, Schouwenberg BJ, Tack CJ, Smits P. Neth J Med; 2006 Sep 30; 64(8):269-79. PubMed ID: 16990690 [Abstract] [Full Text] [Related]
13. Insulin therapy and hypoglycaemia: the size of the problem. Fanelli CG, Porcellati F, Pampanelli S, Bolli GB. Diabetes Metab Res Rev; 2004 Sep 30; 20 Suppl 2():S32-42. PubMed ID: 15551297 [Abstract] [Full Text] [Related]
14. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, Nørgaard K, Perrild H, Parving HH, Thorsteinsson B, Tarnow L. Diabetes Res Clin Pract; 2012 Apr 30; 96(1):17-23. PubMed ID: 22136722 [Abstract] [Full Text] [Related]
15. Clinical characterisation of severe hypoglycaemia--a prospective population-based study. Holstein A, Plaschke A, Egberts EH. Exp Clin Endocrinol Diabetes; 2003 Sep 30; 111(6):364-9. PubMed ID: 14520604 [Abstract] [Full Text] [Related]
17. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes. Boyle PJ, Zrebiec J. Diabetes Metab Res Rev; 2008 Sep 30; 24(4):257-85. PubMed ID: 18232062 [Abstract] [Full Text] [Related]
18. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Barnett AH, Cradock S, Fisher M, Hall G, Hughes E, Middleton A. Int J Clin Pract; 2010 Jul 30; 64(8):1121-9. PubMed ID: 20236369 [Abstract] [Full Text] [Related]
19. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine. Janka HU. Diabetes Obes Metab; 2008 Jul 30; 10 Suppl 2():35-41. PubMed ID: 18577155 [Abstract] [Full Text] [Related]
20. Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? Heller SR. Int J Clin Pract Suppl; 2002 Jul 30; (129):27-32. PubMed ID: 12166602 [Abstract] [Full Text] [Related] Page: [Next] [New Search]